BioCentury
ARTICLE | Company News

Norak, AstraZeneca deal

November 8, 2004 8:00 AM UTC

Under a second license agreement, AZN will use Norak's Transfluor fluorescence-based GPCR technology to advance lead compounds discovered under the companies' 2002 high throughput screening deal. ...